FDA Inspection 1309166 — Imaging Endpoints II, LLC
The FDA completed an inspection of Imaging Endpoints II, LLC on Mar 12, 2026 in Scottsdale, AZ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 12, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Scottsdale, AZ (United States)
Additional details
Sponsor, Contract Research Organization